Thompson Davis & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-125
Closed -$3K 735
2018
Q2
$3K Buy
+125
New +$2.58K 0.01% 575
2016
Q3
Sell
-750
Closed -$6K 1113
2016
Q2
$6K Buy
+750
New +$4.32K 0.01% 751
2015
Q4
Sell
-250
Closed -$1K 1146
2015
Q3
$1K Buy
+250
New +$1.36K ﹤0.01% 1082
2014
Q3
Sell
-1,000
Closed -$3K 1167
2014
Q2
$3K Buy
1,000
+500
+100% +$1.73K ﹤0.01% 680
2014
Q1
$2K Hold
500
﹤0.01% 753
2013
Q4
$3K Buy
+500
New +$2.75K ﹤0.01% 620

Other funds holding EXEL

Thompson Davis & Co's EXEL Position: Q3 2018 in Review

Thompson Davis & Co sold out of Exelixis (EXEL) in Q3 2018, closing a stake of 125 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in EXEL in Q4 2013 and held it in 6 quarters. The position peaked at $6K in Q2 2016. 316 funds tracked by Wall St. Rank hold EXEL as of Q3 2018.

  • Thompson Davis & Co reported no remaining Exelixis position as of Q3 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 125 Exelixis shares in Q3 2018, an estimated $3K.
  • Thompson Davis & Co first reported a position in Exelixis in Q4 2013 and held it in 6 quarters.
  • Thompson Davis & Co's Exelixis position peaked at $6K in Q2 2016.
  • 316 funds tracked by Wall St. Rank held Exelixis as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.